Rumor of the day: JnJ aiming for Auris

Sources say Johnson & Johnson is negotiating a deal to buy Auris, now that its Monarch system has taken off: 

"J&J is seeking to purchase Auris at a premium to the valuation from its latest funding round, according to the people, who asked not to be identified because the information is private. That financing valued the Redwood City, California-based company at about $2 billion, one person said." 

Source: FierceBiotech, Bloomberg